Literature DB >> 27062385

A unique LAMB3 splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries.

B Mayer1, P Silló1, M Mazán1, D Pintér1, M Medvecz1, C Has2, D Castiglia3, F Petit4, A Charlesworth5, Zs Hatvani1, H Pamjav6, S Kárpáti7.   

Abstract

BACKGROUND: We have encountered repeated cases of recessive lethal generalized severe (Herlitz-type) junctional epidermolysis bullosa (JEB gen sev) in infants born to Hungarian Roma parents residing in a small region of Hungary.
OBJECTIVES: To identify the disease-causing mutation and to investigate the genetic background of its unique carrier group.
METHODS: The LAMB3 gene was analysed in peripheral-blood genomic DNA samples, and the pathological consequences of the lethal defect were confirmed by cutaneous LAMB3cDNA sequencing. A median joining haplotype network within the Y chromosome H1a-M82 haplogroup of individuals from the community was constructed, and LAMB3 single-nucleotide polymorphism (SNP) patterns were also determined.
RESULTS: An unconventional intronic splice-site mutation (LAMB3, c.1133-22G>A) was identified. Thirty of 64 voluntarily screened Roma from the closed community carried the mutation, but none of the 306 Roma from other regions of the country did. The age of the mutation was estimated to be 548 ± 222 years. Within the last year, more patients with JEB gen sev carrying the same unusual mutation have been identified in three unrelated families, all immigrants from the Balkans. Two were compound heterozygous newborns, in Germany and Italy, and one homozygous newborn died in France. Only the French family recognized their Roma background. LAMB3SNP haplotyping confirmed the link between the apparently unrelated Hungarian, German and Italian male cases, but could not verify the same background in the female newborn from France.
CONCLUSIONS: The estimated age of the mutation corresponds to the time period when Roma were wandering in the Balkans.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27062385     DOI: 10.1111/bjd.14646

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.

Authors:  Aaron Tabor; Joseph V Pergolizzi; Guy Marti; John Harmon; Bernard Cohen; Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2017-05-01

Review 2.  Advances in understanding the molecular basis of skin fragility.

Authors:  Cristina Has
Journal:  F1000Res       Date:  2018-03-06

3.  LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.

Authors:  Hong Zhang; Yao-Zhen Pan; May Cheung; Mary Cao; Chao Yu; Ling Chen; Lei Zhan; Zhi-Wei He; Cheng-Yi Sun
Journal:  Cell Death Dis       Date:  2019-03-08       Impact factor: 8.469

4.  Targeted next-generation sequencing identifies a novel mutation of LAMB3 in a Chinese neonatal patient presented with junctional epidermolysis bullosa.

Authors:  Hairong Wang; Yun Yang; Jieqiong Zhou; Jiangxia Cao; Xuelian He; Long Li; Shuyang Gao; Bing Mao; Ping Tian; Aifen Zhou
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

6.  Visualization of Keratin with Diffuse Reflectance and Autofluorescence Imaging and Nonlinear Optical Microscopy in a Rare Keratinopathic Ichthyosis.

Authors:  Pálma Anker; Luca Fésűs; Norbert Kiss; Judit Noll; Krisztina Becker; Enikő Kuroli; Balázs Mayer; Szabolcs Bozsányi; Kende Lőrincz; Ilze Lihacova; Alexey Lihachev; Marta Lange; Norbert Wikonkál; Márta Medvecz
Journal:  Sensors (Basel)       Date:  2021-02-05       Impact factor: 3.576

7.  Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.

Authors:  Caiqun Huang; Jun Chen
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.